Insights showcasing the latest thinking from our analysts, portfolio managers, Janus executives and industry experts.
Hillary Clinton introduced a new proposal to address pharmaceutical pricing, affordability and comparative effectiveness for the pharmaceutical industry. Janus research analyst Ethan Lovell weighs in on the potential impact of the proposal, which is already causing volatility within the sector.
A sea change is underway in equity markets. An era of complacency is washing away, as the anticipation of rising rates and global economic concerns usher in a market more grounded in reality.
Monthly insight from Bill Gross, one of the world’s foremost thought leaders on fixed income investing, and Portfolio Manager of the Janus Unconstrained Bond Fund.
Read the latest insights from our research team and see how they are navigating the opportunities and risks within their sectors.